Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Kazia Therapeutics Begins Trial of Paxalisib and Immunotherapy for Advanced Breast Cancer
Friday, January 31, 2025Kazia Therapeutics has received regulatory approval to initiate a clinical trial evaluating a combination of paxalisib and immunotherapy for patients with advanced breast cancer
Orion and Invenra Partner to Develop Bispecific Antibody Cancer Therapies
Friday, January 31, 2025Orion has entered into a collaboration with Invenra to advance the discovery and development of bispecific antibodies for cancer treatment Antibody cancer therapies use engineered antibodies to target and destroy cancer cells while minimising damage...
ImmunityBio and BeiGene Collaborate on Phase 3 ANKTIVA® Trial for NSCLC Treatment
Thursday, January 30, 2025ImmunityBio has announced a collaboration and supply agreement with BeiGene to conduct a confirmatory Phase clinical trial for a combination therapy in nonsmall cell lung cancer NSCLC ANKTIVA is an IL agonist designed to enhance immune responses aga...
Novo Nordisk's Ozempic® Approved to Reduce Kidney Disease and Cardiovascular Death Risk
Wednesday, January 29, 2025Novo Nordisk has received approval from the US Food and Drug Administration FDA for Ozempic semaglutide to reduce the risk of worsening kidney disease kidney failure and death due to cardiovascular disease in adults with type diabetes and chronic
Daiichi Sankyo and AstraZeneca’s ENHERTU® Secures US FDA Approval for Advanced HER2 Low and Ultralow Breast Cancer
Tuesday, January 28, 2025Daiichi Sankyo and AstraZenecas ENHERTU has received US FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor HRpositive HER low IHC or IHC ISH or HER ultralow IHC with membrane staining breast cancer
Apellis Receives Approval for SYFOVRE® (pegcetacoplan) to Treat Geographic Atrophy (GA)
Tuesday, January 28, 2025Apellis Pharmaceuticals has announced the approval of SYFOVRE pegcetacoplan by Australias Therapeutic Goods Administration TGA for the treatment of geographic atrophy GA secondary to agerelated macular degeneration AMD
Neurocrine Biosciences Enters into Collaboration with Takeda for Osavampator Development
Tuesday, January 28, 2025Neurocrine Biosciences has updated its partnership with Takeda to develop and commercialise osavampator NBITAK a potential firstinclass AMPA positive allosteric modulator aimed at treating major depressive disorder MDD
Alvotech and Teva Announce FDA BLA Acceptance for AVT05, Biosimilar to Simponi®
Monday, January 27, 2025Alvotech and Teva Pharmaceuticals have confirmed that the US Food and Drug Administration FDA has accepted the Biologics License Applications BLA for AVT a proposed biosimilar to Simponi and Simponi Aria golimumab
Ocugen Announces FDA Approval of OCU500 Inhaled Vaccine for COVID-19
Monday, January 27, 2025Ocugen has received confirmation from the US Food and Drug Administration FDA that its Investigational New Drug IND application for OCU an inhaled mucosal vaccine for COVID is now in effect
AstraZeneca Announces C$820 Million Investment for Global Expansion and Innovation
Friday, January 24, 2025AstraZeneca has announced plans to invest C million US million in CanadaThe initiative is expected to create over highskilled jobs across various areas of its business and will include the development of a new stateoftheart office facility in the Gr...
